Global Injectable Drug Delivery Market Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023

  • ID: 4342113
  • Report
  • Region: Global
  • 190 Pages
  • Occams Business Research and Consulting
1 of 4
Global Inject Able Drug Delivery Market is Expected to Rise at a CAGR of 12% During 2016-2023

FEATURED COMPANIES

  • Gerresheimer Ag (Germany)
  • Hospira Inc. (U.S.)
  • Nono Nordisk (Denmark)
  • Pfizer (U.S.)
  • Sanofi Sa (France)
  • Schott Ag (Germany)
  • MORE

Injectable drug delivery is used for direct introduction of a pharmaceutical drug in body of the patient with the help of a delivery device. The global inject able drug delivery market is expected to rise at a CAGR of 12% during the forecast period 2016-2023. Growth in pharmaceutical and biotechnology industry is contributing to the growth of the global inject able drug delivery market. However, infection associated with needle stick injury is the factor restraining the growth of the global inject able drug delivery market during the forecast period.

Geographically, North America accounted for the largest market share in terms of revenue for inject able drug delivery market in 2016 and the region is expected to dominate the market during the forecast period followed by Europe. The dominance of the region is attributed to technologically advanced healthcare facilities in the countries of the region. However, Asia Pacific is expected to be the fastest growing region for inject able drug delivery market during the forecast period. The highest growth in the region is observed due to enhancing healthcare infrastructure and prevalence of chronic diseases in the region.

The growth in global inject able drug delivery market is also influenced by the presence of major players such as Baxter International (U.S.), Schott AG (Germany), Terumo Corporation (U.S.), Hospira Inc. (U.S.), Sanofi SA (France) etc. The market players adopt some crucial strategies such as product launches, partnerships, mergers & acquisitions etc.to gain competitive advantage.

Global inject able drug delivery market report covers segmentation analysis of type, formulation, therapeutic application, usage pattern and end users. Report further covers segmentsof type which includes device and formulations. Device is expected to dominate the segment during the forecast period owing to rising usage in management and control of various disorders at primary level. Formulation packaging in inject able drug delivery is divided as ampoules, bottles, cartridges and vials. Moreover, therapeutic applications of inject able drug delivery include auto immune diseases, hormonal disorders, oncology, orphan diseases and other applications.

Oncology is expected to dominate the segment during the forecast period owing to increasing application of inject able drug delivery in diagnosis and treatment of cancer and diabetes. Furthermore, usage pattern segment of inject able drug delivery can be sub divided as curative care, immunization and others. Also, end users of inject able drug delivery include hospitals, homecare and others (Research institutes, clinical, diagnostic laboratories). Homecare segment is expected to dominate the segment during the forecast period owing to increasing demand for self-injection devices which provides easy administration of drugs at home without medical assistance.



Note:
Please allow up to 72 hours for delivery.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Gerresheimer Ag (Germany)
  • Hospira Inc. (U.S.)
  • Nono Nordisk (Denmark)
  • Pfizer (U.S.)
  • Sanofi Sa (France)
  • Schott Ag (Germany)
  • MORE

1. Introduction
1.1. Executive Summary
1.2. Estimation Methodology
 
2. Market Overview
2.1. Injectable Drug Delivery Market: Evolution & Transition
2.2. Market Definition & Scope
2.3. Industry Structure
2.4. Regulatory Framework
2.5. Total Market Analysis
2.5.1. Top 5 Findings
2.5.2. Top 5 Opportunity Markets
2.5.3. Top 5 Companies
2.5.4. Top 3 Competitive Strategies
2.6. Estimation Analysis
2.7. Strategic Analysis
2.7.1. Investment Vs. Adoption Model
2.7.2. 360-Degree Industry Analysis
2.7.3. Porters 5 Force Model
2.7.4. See-Saw Analysis
2.7.5. Consumer Analysis And Key Buying Criteria
2.8. Competitive Analysis
2.8.1. Key Strategies & Analysis
2.8.2. Market Share Analysis And Top Company Analysis
2.9. Strategic Recommendations & Key Conclusions
2.9.1. Investment Opportunities By Regions
2.9.2. Opportunities in Emerging Applications
2.9.3. Investment Opportunity in Fastest Growing Segment
 
3. Market Determinants
3.1. Market Drivers
3.1.1. Increased Demand for Self Injection Devices
3.1.2. Rising Prevalence of Chronic Diseases
3.1.3. Technological Advancements in Medical Industry
3.1.4. New Product Launches
3.1.5. Growth in Biologics Market
3.2. Market Restraints
3.2.1. Infections Associated With Needllestick Injuries
3.3. Market Opportunities
3.3.1. Increasing Demand for Biosimilar And Generic Injectables
3.3.2. Increasing Applications of Contraceptive Injectables
3.4. Market Challenges
3.4.1. Preference for Other Modes of Drug Delivery
 
4. Market Segmentation
4.1.1. Injectable Drug Delivery Market By Type
4.1.2. Market Definition And Scope
4.1.3. Decision Support Database & Estimation Methodology
4.1.4. Comparative Analysis Across Market Segments
4.1.5.  Opportunity Matrix
4.1.6. Market Segmentation
4.1.6.1. Global Devices Market
4.1.6.1.1. Adoption Scenario & Market Determinants
4.1.6.1.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.1.6.1.3. Top Players & Key Products
4.1.6.1.4. Key Conclusions
4.1.6.2. Global Formulations Market
4.1.6.2.1. Adoption Scenario & Market Determinants
4.1.6.2.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.1.6.2.3. Top Players & Key Products
4.1.6.2.4. Key Conclusions
4.2. Injectable Drug Deliverymarket By Formulation
4.2.1. Market Definition And Scope
4.2.2. Decision Support Database & Estimation Methodology
4.2.3. Comparative Analysis Across Market Segments
4.2.4.  Opportunity Matrix
4.2.5. Market Segmentation
4.2.5.1. Global Ampules Market
4.2.5.1.1. Application
4.2.5.1.2. Adoption Scenario & Market Determinants
4.2.5.1.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.2.5.1.4. Top Players & Key Products
4.2.5.1.5. Key Conclusions
4.2.5.2. Global Bottles Market
4.2.5.2.1. Application
4.2.5.2.2. Adoption Scenario & Market Determinants
4.2.5.2.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.2.5.2.4. Top Players & Key Products
4.2.5.2.5. Key Conclusions
4.2.5.3. Global Cartridges Market
4.2.5.3.1. Application
4.2.5.3.2. Adoption Scenario & Market Determinants
4.2.5.3.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.2.5.3.4. Top Players & Key Products
4.2.5.3.5. Key Conclusions
4.2.5.4. Global Vials Market
4.2.5.4.1. Application
4.2.5.4.2. Adoption Scenario & Market Determinants
4.2.5.4.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.2.5.4.4. Top Players & Key Products
4.2.5.4.5. Key Conclusions
4.3. Injectable Drug Deliverymarket By Therapeutic Application
4.3.1. Market Definition And Scope
4.3.2. Decision Support Database & Estimation Methodology
4.3.3. Comparative Analysis Across Market Segments
4.3.4.  Opportunity Matrix
4.3.5. Market Segmentation
4.3.5.1. Global Auto Immune Diseases Market
4.3.5.1.1. Application
4.3.5.1.2. Adoption Scenario & Market Determinants
4.3.5.1.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.3.5.1.4. Top Players & Key Products
4.3.5.1.5. Key Conclusions
4.3.5.2. Global Hormonal Disorders Market
4.3.5.2.1. Application
4.3.5.2.2. Adoption Scenario & Market Determinants
4.3.5.2.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.3.5.2.4. Top Players & Key Products
4.3.5.2.5. Key Conclusions
4.3.5.3. Global Oncology Market
4.3.5.3.1. Application
4.3.5.3.2. Adoption Scenario & Market Determinants
4.3.5.3.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.3.5.3.4. Top Players & Key Products
4.3.5.3.5. Key Conclusions
4.3.5.4. Global Orphan Diseases Market
4.3.5.4.1. Application
4.3.5.4.2. Adoption Scenario & Market Determinants
4.3.5.4.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.3.5.4.4. Top Players & Key Products
4.3.5.4.5. Key Conclusions
4.3.5.5. Global Others Market
4.3.5.5.1. Application
4.3.5.5.2. Adoption Scenario & Market Determinants
4.3.5.5.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.3.5.5.4. Top Players & Key Products
4.3.5.5.5. Key Conclusions
4.4. Injectable Drug Deliverymarket By Usage Pattern
4.4.1. Market Definition And Scope
4.4.2. Decision Support Database & Estimation Methodology
4.4.3. Comparative Analysis Across Market Segments
4.4.4.  Opportunity Matrix
4.4.5. Market Segmentation
4.4.5.1. Global Curative Care Market
4.4.5.1.1. Application
4.4.5.1.2. Adoption Scenario & Market Determinants
4.4.5.1.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.4.5.1.4. Top Players & Key Products
4.4.5.1.5. Key Conclusions
4.4.5.2. Global Immunization Market
4.4.5.2.1. Application
4.4.5.2.2. Adoption Scenario & Market Determinants
4.4.5.2.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.4.5.2.4. Top Players & Key Products
4.4.5.2.5. Key Conclusions
4.4.5.3. Global Others Market
4.4.5.3.1. Application
4.4.5.3.2. Adoption Scenario & Market Determinants
4.4.5.3.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.4.5.3.4. Top Players & Key Products
4.4.5.3.5. Key Conclusions
4.5. Injectable Drug Deliverymarket By End User
4.5.1. Market Definition And Scope
4.5.2. Decision Support Database & Estimation Methodology
4.5.3. Comparative Analysis Across Market Segments
4.5.4.  Opportunity Matrix
4.5.5. Market Segmentation
4.5.5.1. Global Hospitals Market
4.5.5.1.1. Application
4.5.5.1.2. Adoption Scenario & Market Determinants
4.5.5.1.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.5.5.1.4. Top Players & Key Products
4.5.5.1.5. Key Conclusions
4.5.5.2. Global Homecare Market
4.5.5.2.1. Application
4.5.5.2.2. Adoption Scenario & Market Determinants
4.5.5.2.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.5.5.2.4. Top Players & Key Products
4.5.5.2.5. Key Conclusions
4.5.5.3. Global Others (Research Institutes, Clinical, Diagnostic Laboratories) Market
4.5.5.3.1. Application
4.5.5.3.2. Adoption Scenario & Market Determinants
4.5.5.3.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.5.5.3.4. Top Players & Key Products
4.5.5.3.5. Key Conclusions
 
5. Competitive Landscape
5.1. Key Strategies
5.1.1. List of Mergers And Acquisition
5.1.2. List of Joint Ventures
5.1.3. List of Product Launches
5.1.4. List of Partnerships
 
6. Geographical Analysis
6.1. Decision Support Database & Estimation Methodology
6.2. Comparative Analysis Across Market Segments
6.3. Opportunity Matrix
6.4. Global Injectable Drug Deliverymarket By Region 2014-2023 ($ Million)
6.4.1. North America
6.4.1.1. Industry Analysis 2014-2023 ($ Million)
6.4.1.2. Top Country Analysis
6.4.1.2.1. U.S.
6.4.1.2.1.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.1.2.1.2. Top Players & Key Products
6.4.1.2.1.3. Key Conclusions
6.4.1.2.2. Canada
6.4.1.2.2.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.1.2.2.2. Top Players & Key Products
6.4.1.2.2.3. Key Conclusions
6.4.2. Europe
6.4.2.1. Industry Analysis 2014-2023 ($ Million)
6.4.2.2. Top Country Analysis
6.4.2.2.1. Uk
6.4.2.2.1.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.1.2. Top Players & Key Products
6.4.2.2.1.3. Key Conclusions
6.4.2.2.2. France
6.4.2.2.2.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.2.2. Top Players & Key Products
6.4.2.2.2.3. Key Conclusions
6.4.2.2.3. Germany
6.4.2.2.3.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.3.2. Top Players & Key Products
6.4.2.2.3.3. Key Conclusions
6.4.2.2.4. Spain
6.4.2.2.4.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.4.2. Top Players & Key Products
6.4.2.2.4.3. Key Conclusions
6.4.2.2.5. Rest of Europe
6.4.2.2.5.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.5.2. Top Players & Key Products
6.4.2.2.5.3. Key Conclusions
6.4.3. Asia Pacific
6.4.3.1. Industry Analysis 2014-2023 ($ Million)
6.4.3.2. Top Country Analysis
6.4.3.2.1. China
6.4.3.2.1.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.1.2. Top Players & Key Products
6.4.3.2.1.3. Key Conclusions
6.4.3.2.2. India
6.4.3.2.2.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.2.2. Top Players & Key Products
6.4.3.2.2.3. Key Conclusions
6.4.3.2.3. Japan
6.4.3.2.3.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.3.2. Top Players & Key Products
6.4.3.2.3.3. Key Conclusions
6.4.3.2.4. Australia
6.4.3.2.4.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.4.2. Top Players & Key Products
6.4.3.2.4.3. Key Conclusions
6.4.3.2.5. Rest of Asia Pacific
6.4.3.2.5.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.5.2. Top Players & Key Products
6.4.3.2.5.3. Key Conclusions
6.4.4. Row
6.4.4.1. Industry Analysis 2014-2023 ($ Million)
6.4.4.2. Top Country Analysis
6.4.4.2.1. Latin America
6.4.4.2.1.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.4.2.1.2. Top Players & Key Products
6.4.4.2.1.3. Key Conclusions
6.4.4.2.2. Middle East & Africa
6.4.4.2.2.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.4.2.2.2. Top Players & Key Products
6.4.4.2.2.3. Key Conclusions
 
7. Company Profiles
7.1. Becton Dickinson And Company (U.S.)
7.1.1. Overview
7.1.2. Product Portfolio
7.1.3. Key Innovation Sector
7.1.4. Strategic Initiatives
7.1.5. Scot Analysis
7.1.6. Strategic Analysis
7.2. Baxter International (U.S.)
7.2.1. Overview
7.2.2. Product Portfolio
7.2.3. Key Innovation Sector
7.2.4. Strategic Initiatives
7.2.5. Scot Analysis
7.2.6. Strategic Analysis
7.3. Pfizer (U.S.)
7.3.1. Overview
7.3.2. Product Portfolio
7.3.3. Key Innovation Sector
7.3.4. Strategic Initiatives
7.3.5. Scot Analysis
7.3.6. Strategic Analysis
7.4. Gerresheimer Ag (Germany)
7.4.1. Overview
7.4.2. Product Portfolio
7.4.3. Key Innovation Sector
7.4.4. Strategic Initiatives
7.4.5. Scot Analysis
7.4.6. Strategic Analysis
7.5. Schott Ag (Germany)
7.5.1. Overview
7.5.2. Product Portfolio
7.5.3. Key Innovation Sector
7.5.4. Strategic Initiatives
7.5.5. Scot Analysis
7.5.6. Strategic Analysis
7.6. Eli Lilly And Company (U.S.)
7.6.1. Overview
7.6.2. Product Portfolio
7.6.3. Key Innovation Sector
7.6.4. Strategic Initiatives
7.6.5. Scot Analysis
7.6.6. Strategic Analysis
7.7. Terumo Corporation (U.S.)
7.7.1. Overview
7.7.2. Product Portfolio
7.7.3. Key Innovation Sector
7.7.4. Strategic Initiatives
7.7.5. Scot Analysis
7.7.6. Strategic Analysis
7.8. Antares Pharma Inc. (U.S.)
7.8.1. Overview
7.8.2. Product Portfolio
7.8.3. Key Innovation Sector
7.8.4. Strategic Initiatives
7.8.5. Scot Analysis
7.8.6. Strategic Analysis
7.9. Hospira Inc. (U.S.)
7.9.1. Overview
7.9.2. Product Portfolio
7.9.3. Key Innovation Sector
7.9.4. Strategic Initiatives
7.9.5. Scot Analysis
7.9.6. Strategic Analysis
7.10. Nono Nordisk (Denmark)
7.10.1. Overview
7.10.2. Product Portfolio
7.10.3. Key Innovation Sector
7.10.4. Strategic Initiatives
7.10.5. Scot Analysis
7.10.6. Strategic Analysis
7.11. Sanofi Sa (France)
7.11.1. Overview
7.11.2. Product Portfolio
7.11.3. Key Innovation Sector
7.11.4. Strategic Initiatives
7.11.5. Scot Analysis
7.11.6. Strategic Analysis
7.12. Scandinavian Health Ltd. (Taiwan)
7.12.1. Overview
7.12.2. Product Portfolio
7.12.3. Key Innovation Sector
7.12.4. Strategic Initiatives
7.12.5. Scot Analysis
7.12.6. Strategic Analysis
7.13. Terumo Corporation (Japan)
7.13.1. Overview
7.13.2. Product Portfolio
7.13.3. Key Innovation Sector
7.13.4. Strategic Initiatives
7.13.5. Scot Analysis
7.13.6. Strategic Analysis
7.14. Unilife Corporation (U.S.)
7.14.1. Overview
7.14.2. Product Portfolio
7.14.3. Key Innovation Sector
7.14.4. Strategic Initiatives
7.14.5. Scot Analysis
7.14.6. Strategic Analysis
7.15. Zogenix Inc. (U.S.)
7.15.1. Overview
7.15.2. Product Portfolio
7.15.3. Key Innovation Sector
7.15.4. Strategic Initiatives
7.15.5. Scot Analysis
7.15.6. Strategic Analysis
 
List of Tables
1. Global Injectable Drug Delivery Market By Type 2014-2023 ($ Million)
2. Global Devices Market By Geography 2014-2023 ($ Million)
3. Global Formulations Market By Geography 2014-2023 ($ Million)
4. Global Injectable Drug Delivery Market By Formulation2014-2023 ($ Million)
5. Global Ampules Market By Geography 2014-2023 ($ Million)
6. Global Bottles Market By Geography 2014-2023 ($ Million)
7. Global Cartridges Market By Geography 2014-2023 ($ Million)
8. Global Vials Market By Geography 2014-2023 ($ Million)
9. Global Injectable Drug Delivery Market By Therapeutic Application 2014-2023 ($ Million)
10. Global Auto Immune Diseases Market By Geography 2014-2023 ($ Million)
11. Global Hormonal Disorders Market By Geography 2014-2023 ($ Million)
12. Global Oncology Market By Geography 2014-2023 ($ Million)
13. Global Orphan Diseases Market By Geography 2014-2023 ($ Million)
14. Global Others Market By Geography 2014-2023 ($ Million)
15. Global Injectable Drug Delivery Market By Usage Pattern2014-2023 ($ Million)
16. Global Curative Care Market By Geography 2014-2023 ($ Million)
17. Global Immunization Market By Geography 2014-2023 ($ Million)
18. Global Others Market By Geography 2014-2023 ($ Million)
19. Global Injectable Drug Delivery Market By End User 2014-2023 ($ Million)
20. Global Hospitals Market By Geography 2014-2023 ($ Million)
21. Global Homecare Market By Geography 2014-2023 ($ Million)
22. Global Others (Research Institutes, Clinical, Diagnostic Laboratories) Market By Geography 2014-2023 ($ Million)
23. North America Injectable Drug Delivery Market 2014-2023 ($ Million)
24. Europe Injectable Drug Delivery Market 2014-2023 ($ Million)
25. Asia Pacific Injectable Drug Delivery Market 2014-2023 ($ Million)
26. Rest of the World Injectable Drug Delivery Market 2014-2023 ($ Million)
 
List of Figures
1. Global Injectable Drug Delivery Market 2014-2023 ($ Million)
2. Global Devices Market 2014-2023 ($ Million)
3. Global Formulations Market 2014-2023 ($ Million)
4. Global Ampules Market 2014-2023 ($ Million)
5. Global Bottles Market 2014-2023 ($ Million)
6. Global Cartridges Market 2014-2023 ($ Million)
7. Global Vials Market 2014-2023 ($ Million)
8. Global Auto Immune Diseases Market 2014-2023 ($ Million)
9. Global Hormonal Disorders Market 2014-2023 ($ Million)
10. Global Oncology Market 2014-2023 ($ Million)
11. Global Orphan Diseases Market 2014-2023 ($ Million)
12. Global Others Market 2014-2023 ($ Million)
13. Global Curative Care Market 2014-2023 ($ Million)
14. Global Immunization Market 2014-2023 ($ Million)
15. Global Others Market 2014-2023 ($ Million)
16. Global Hospitals Market 2014-2023 ($ Million)
17. Global Homecare Market 2014-2023 ($ Million)
18. Global Others (Research Institutes, Clinical, Diagnostic Laboratories) Market 2014-2023 ($ Million)
19. United States (U.S.) Injectable Drug Delivery Market 2014-2023 ($ Million)
20. Canada Injectable Drug Delivery Market 2014-2023 ($ Million)
21. United Kingdom (Uk) Injectable Drug Delivery Market 2014-2023 ($ Million)
22. France Injectable Drug Delivery Market 2014-2023 ($ Million)
23. Germany Injectable Drug Delivery Market 2014-2023 ($ Million)
24. Spain Injectable Drug Delivery Market 2014-2023 ($ Million)
25. Roe Injectable Drug Delivery Market 2014-2023 ($ Million)
26. India Injectable Drug Delivery Market 2014-2023 ($ Million)
27. China Injectable Drug Delivery Market 2014-2023 ($ Million)
28. Japan Injectable Drug Delivery Market 2014-2023 ($ Million)
29. Australia Injectable Drug Delivery Market 2014-2023 ($ Million)
30. Roapac Injectable Drug Delivery Market 2014-2023 ($ Million)
31. Latin America Injectable Drug Delivery Market 2014-2023 ($ Million)
32. Mena Injectable Drug Delivery Market 2014-2023 ($ Million)

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Antares Pharma Inc. (U.S.)
  • Baxter International (U.S.)
  • Becton Dickinson And Company (U.S.)
  • Eli Lilly And Company (U.S.)
  • Gerresheimer Ag (Germany)
  • Hospira Inc. (U.S.)
  • Nono Nordisk (Denmark)
  • Pfizer (U.S.)
  • Sanofi Sa (France)
  • Scandinavian Health Ltd. (Taiwan)
  • Schott Ag (Germany)
  • Terumo Corporation (Japan)
  • Terumo Corporation (U.S.)
  • Unilife Corporation (U.S.)
  • Zogenix Inc. (U.S.)
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll